Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
amyloid beta
Research
Anti-nausea drug reduces Alzheimer's-advancing cells in mice
A drug candidate based on aprepitant was reported to reduce the brain area of astrocytes and improve cognitive function in a mouse model.
Darren Incorvaia
Sep 17, 2024 4:52pm
FDA revises guidance on predicting Alzheimer's drug benefits
Mar 12, 2024 7:40am
Alzheimer's transmission via procedure may boost prion theory
Jan 31, 2024 1:27pm
Roche’s Genentech returns Alzheimer’s assets to AC Immune
Jan 22, 2024 8:47am
Acumen posts early Alzheimer's data for next-gen Leqembi rival
Jul 17, 2023 5:32am
Roche nabs FDA nod for another pair of CSF tests for Alzheimer's
Jun 28, 2023 4:37pm
